An investigation is being conducted by Ademi LLP into potential securities fraud allegations against PROCEPT BioRobotics (NASDAQ: PRCT) following suspicions of misleading statements made by the company about its financial statements and business operations. The inquiry, stemming from concerns over the accuracy of information provided, aims to determine the extent of any fraudulent activities. This raises doubts about the integrity of the company's disclosures and financial performance, impacting shareholders and investors.